PF-3758309 showed permeability of 0.9 × 10−6 cm/s in MDCKII-LE transwell assays. In HCT116 cells treated for 24 h, 4935 genes were upregulated and 6544 genes were downregulated at the mRNA level. Treatment at 1 μmol/L for 8 h decreased P-S675 in the PF-3758309-sensitive HCT116 cell line. [1,2,3]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
Transwell Permeability in MDCKII-LE Cells
Cell-based study · MDCKII-LE cells [1]
The study compound was evaluated in MDCKII-LE cells using transwell assays with DMSO as the vehicle. A permeability value was reported.
Literature-Reported Treatment Conditions
- Method
- transwell assays
- Vehicle
- DMSO
- Reported limits
- Not stated in the sentences used: dose, schedule, control.
Methods and source locations
Compound reported in the paper: PF-3758309; Compound label in the paper: PF-309
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and Methods > Chemicals and reagents (S2); Results > PF-3758309 is a substrate for P-glycoprotein and breast cancer resistance protein (S94, S95)
permeability: permeability — Results > PF-3758309 is a substrate for P-glycoprotein and breast cancer resistance protein (S95)
Treatment Alters mRNA Levels in HCT116 Cells
Cell-based study · HCT116 cells [2]
In HCT116 cells treated with the study compound for 24 h, 4935 genes were upregulated and 6544 genes were downregulated at the mRNA level relative to the DMSO control.
Literature-Reported Treatment Conditions
- Exposure duration
- 24 h
- Vehicle
- DMSO
- Reported limits
- Not stated in the sentences used: dose, route.
Methods and source locations
Compound reported in the paper: PF-3758309
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Results > Multi-Omics analysis identified new potential targets of PF-3758309 (S15, S32); Materials and methods > RNA-seq (S197)
Global changes in mRNA levels: Global changes in mRNA levels; comparator: DMSO — Results > Multi-Omics analysis identified new potential targets of PF-3758309 (S15, S32)
Reduced phosphorylation readout in a sensitive cell line
Cell-based study · HCT116 [3]
PF-3758309 treatment at 1 μmol/L for 8 h decreased P-S675 in the PF-3758309-sensitive HCT116 cell line.
Literature-Reported Treatment Conditions
- Treatment concentration
- 1 μmol/L
- Exposure duration
- 8 h
- Method
- treated
- Vehicle
- dimethyl sulfoxide (DMSO)
- Reported limits
- Not stated in the sentences used: control.
Methods and source locations
Compound reported in the paper: PF-3758309
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
MATERIALS AND METHODS > CELL CULTURE AND PROLIFERATION (S8); RESULTS > EVALUATION OF DOWNSTREAM EFFECTORS BY A PHOSPHO-KINASE ARRAY AND IMMUNOBLOTTING (S107); FIGURE 3 legend (S143)
P-S675: P-S675 — RESULTS > EVALUATION OF DOWNSTREAM EFFECTORS BY A PHOSPHO-KINASE ARRAY AND IMMUNOBLOTTING (S107)